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Introduction
The main differences between lipids and other biomolecules 
(carbohydrates, proteins and nucleic acids) are their solubility in 
non-polar solvents and structure of long hydrocarbon chains. Based 
on the physical and chemical properties, eukaryotic and prokaryotic 
lipids are grouped under eight categories, each of which contains 
distinct classes, subclasses, subgroups and subsets of lipid molecules 
(Table 1) [1]. When studying lipids from a system scale, one of the key 
challenges is to address the lipid functionality at many physiological 
levels from metabolism, signaling pathways to spatial regulation, 
as well as the interactions with other “Omics”. Lipidomics is to map 
the entire spectrum of cellular lipids in biological systems, including 
metabolic pathways, lipid–lipid and lipid-protein interactions [2]. It 
complements proteomics, genomics and metabolomics for providing 
a more comprehensive understanding of system biology in health and 
disease [3]. 
As lipids are not genetically encoded, the total number of distinct 
chemical entities in lipidome is poorly defined. In general, lipids 
are derived from the condensation of two distinct types of building 
blocks, ketoacyl or isoprene subunits [4,5]. However, the biosynthetic 
and metabolic pathways of lipids are enormously diversified. Due to 
the combinatorial nature of lipid biosynthesis, the various backbone, 
headgroup and acyl chains can give rise to thousands of lipid species. 
The dynamic nature of lipidomics requires not only better analytical 
techniques, but also tactical sample processing and integrative 
computational tools. Due largely to the advanced technology 
development, lipidomics is now opening a novel avenue in the 
discovery of biomarkers for predictive and preventive medicine. This 
review focuses on the strategies to study lipids in health and disease, 
with specific emphasis on lipid-protein interactions.
Biosynthesis and Metabolism of Lipids
Lipids are a diverse group of hydrophobic or amphipathic small 
molecules that possess many functions, including the maintenance 
of membrane structure, energy storage, signal transduction and 
regulation of gene expression (Hyotylainen and Oresic, 2014). Lipids 
are generated and metabolized by enzymes. The metabolism of lipids 
is regulated by a coordinated network of signaling pathways that are 
dynamically regulated by the environment. Virtually all lipid pathways 
are interconnected and perturbations in one branch usually will affect 
the entire lipid metabolic network (i.e. resulting in global lipidome 
changes). Thus, understanding the anabolism and catabolism of lipids 
is essential for research and development in the field of lipidomics. 
Furthermore, altered lipid metabolism plays important roles in the 
pathogenesis of most of the common diseases, such as type 2 diabetes, 
cancers, coronary artery and neurodegenerative diseases. Here, the 
major classes of lipids, including glycerolipids, glycerophospholipids, 
sphingolipids and sterol lipids, will be discussed.
Fatty acids and their derivatives
Fatty acids are aliphatic monocarboxylic acids with a large 
diversity in structure ranging from simple saturated carbon chains to 
unsaturated, branched, cyclic and cis/trans configurations. According 
to the length of carbon atoms, they are classified as short (less than 6 
carbons), medium (from 6 to 12 carbons), long (from 13 to 21 carbons) 
and very long (more than 22 carbons) chain fatty acids. In addition, 
functional groups including keto, hydroxyl, peroxy and epoxy groups 
can be attached to fatty acids. The majority of fatty acids exist in the 
form of esters and amides. Free fatty acids constitute only a small 
portion of the total fatty acids [6]. 
Fatty acids are stored primarily as triacylglycerols and sterol esters 
[7]. Because of the highly reduced chemical structure, fatty acids yield 
more than twice as much energy upon oxidation compared with 
polysaccharides, which allows fat to be the most efficient form for 
storing excess energy. On demand, fatty acids are released from storage 
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Abstract
The role of lipids in human health and disease is taking the center stage. In the last decades, there has been an 
intense effort to develop suitable methodologies to discover, identify, and quantitatively monitor lipids in biological 
systems. Recent advancement of mass spectrometry technology has provided a variety of tools for global study of the 
lipid “Omes”, including the quantification of known lipid molecular species and the identification of novel lipids that possess 
pathophysiological functions. Lipidomics has thus emerged as a discipline for comprehensively illuminating lipids, lipid-
derived mediators and lipid networks in body fluids, tissues and cells. However, owing to the complexity and diversity of 
the lipidome, lipid research is challenging. Here, the experimental strategies for lipid isolation and characterization will 
be presented, especially for those who are new to the field of lipid research. Because lipids are known to participate in 
a host of protein signaling and trafficking pathways, the review emphasizes the understanding of interactions between 
cellular components, in particular the lipid-protein interrelationships. Novel tools for probing lipid-protein interactions by 
advanced mass spectrometric techniques will be discussed. It is expected that by integrating the approaches of lipidomics, 
transcriptomics and proteomics, a clear understanding of the complex functions of lipids will eventually be translated into 
human diseases.
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Category Core structure Classes/Subclasses
Fatty acyls Fatty acids and conjugates, Fatty esters, fatty alcohols, Fatty amides, eicosanoids
Glycerolipids
Monoacylglycerols, Monogalactosyldiacylglycerols, 
Diacylglycerols,
Digalactosyldiacylglycerols,
Triacylglycerols
Glycerophospholipids
Phosphatidic acids, Phosphatidylethanolamine,
Phosphatidylcholine,
Phosphatidylglycerols, Phosphatidylserines,
Phosphatidylinositols, Cardiolipins
Sphingolipids Ceramides, sphingosines, Sphingosine-1-phosphates, Ganglio-side mannoside 3, Sphingomyelins Sulfatides
Sterol lipids
Cholesterols,
Cholesteryl esters,
Cholesteryl sulfates,
Steroids,
Bile acids
Prenol lipids
HO
HO
HO
O
O
O
O
P P
Isoprenoids,
Polyprenoids,
Quinines,
Hydroquinines,
Saccharolipids
Acylaminosugars,
Acylaminosugar glycans, 
Acyltrehaloses, 
Acyltrehaloses glycans
Polyketides
Macrolide polyketides,
Aromatic polyketides,
Non-ribosomal peptide/polyketide hybrids
Table 1: Categories, classes and subclasses of lipids 
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or membrane lipids by hydrolysis mediated by lipases. Fatty acids are 
synthesized de novo from acetyl-CoA by fatty acid synthase (FAS) to 
yield palmitate (16:0), which then be either desaturated to palmitoleate 
(16:1) by stearoyl-CoA desaturase (SCD) or elongated by an elongase 
(ELOVL6) to stearate (18:0) [8]. Stearate can be further desaturated 
to oleate (18:1) by SCD [9]. Eukaryotes lack the enzymatic system to 
introduce double bonds at position omega (ω)-6 or lower. Thus, these 
subtypes of fatty acids or their precursors are obtained from the diet. 
In human, linoleic acid (18:2, ω-6) and alpha-linolenic acid (18:3, ω-3) 
are essential fatty acids and form the parent molecules for arachidonic 
(AA, 20:4) and eicosapentaenoic acid (EPA, 20:5)/ docosahexaenoic 
acid (DHA, 22:6), respectively. AA, EPA and DHA, are commonly 
found at the sn-2 position of glycerophospholipids for the synthesis 
of classical (prostaglandins leukotrienes, thromboxanes, lipoxins) 
and nonclassical (endocannabinoids, neuroprotectins and resolvins) 
eicosanoids [10]. In mammals, fatty acid synthesis and metabolism are 
tightly controlled by the nuclear transcription factor sterol regulatory 
element binding proteins (SREBP), which regulate genes such as FAS, 
SCD and ELOVL6 [11]. 
Historically, fatty acids were considered to be simple membrane 
components serving as the basic building blocks for various complex 
lipids, such as glycerolipids and glycerophospholipids [12]. It is 
increasingly recognized that fatty acids are important signaling 
molecules regulating cellular homeostasis and functions [13]. As the 
integral components of cellular membranes, fatty acid composition 
determines the fluidity and the movement of molecules within and 
across the membrane, the activity of membrane proteins and receptors, 
the arrangement of membrane microdomains, the trafficking and 
signal transduction processes [14]. With the help of transporting 
proteins, fatty acids are distributed via blood circulation to organs and 
act as ligands of G protein-coupled receptors (e.g. GPR41 and GPR43) 
and nuclear receptors (e.g. PPARα), which play crucial roles in the 
regulation of energy expenditure [15]. Aberrant fatty acid metabolism 
causes pathological consequences, including insulin resistance, 
diabetes, cancer, fatty liver and cardiovascular diseases [16,17,18]. 
Glycerophospholipids 
Lipids with a phosphate functional group are classified as 
phospholipids, which account for ~60% lipid mass in eukaryotic 
cells [19]. Phospholipids, including glycerophospholipids and 
phosphosphingolipids, are the primary building blocks of biological 
membranes and the precursors for signaling molecules such as inositol 
triphosphate and diacylglycerol, which are produced by various 
phospholipases [20]. Phospholipids are also sources of lipid mediators, 
including prostaglandins and leukotrienes that regulate cell homeostasis 
and inflammation [21,22]. Changes in profile and concentration of 
phospholipids can result in major consequences on cell function and 
viability. For example, translocation of the phosphatidylserine head 
group to the outer leaflet of the plasma membrane is involved in 
cellular apoptosis and the recognition by macrophages for subsequent 
phagocytosis [23-31]. Drugs-induced phospholipidosis is one of the 
major concerns in drug development and clinical treatment [24].
Glycerophospholipids consist of a glycerol backbone with a 
hydrophilic head group at sn-3 position and different combinations of 
fatty acids at sn-1 and sn-2 positions. Saturated or monounsaturated 
fatty acids are mainly found at sn-1 position, whereas polyunsaturated 
fatty acids conjugated at sn-2 position. The polar head groups 
define the subclasses of glycerophospholipids (Table 1). During 
glycerophospholipids synthesis, the first step is the transfer of a fatty acid 
to glycerol-3-phosphate to form lysophosphatidic acid (LPA), which is 
further acylated to phosphatidic acid (PA). After conversion to CDP-
diacylglycerol, PA provides the precursor for phosphatidylinositol and 
phosphatidylglycerol. Alternatively, PA is dephosphorylated to generate 
diacylglycerol, which fuels the synthesis of phosphatidylcholine, 
phosphatidylethanolamine and phosphatidylserine. Phosphorylated 
choline/ethanolamine are converted to CDP-choline/ethanolamine, 
which are then used for head groups of phosphatidylcholine and 
phosphatidylethanolamine, respectively (the so-called Kennedy 
pathway). Both phosphatidylcholine and phosphatidylethanolamine 
are substrates for phosphatidylserine synthesis, which may be 
converted to phosphatidylethanolamine by decarboxylation in the 
mitochondria. Thus, the metabolism of phosphatidylethanolamine and 
phosphatidylserine is tightly linked. Phosphatidylethanolamine can 
be derived additionally from N-methylation of phosphatidylcholine 
(Figure 1). These pathways generate glycerophospholipids with 
different profiles of fatty acid tails. The CDP-choline pathway produces 
those with medium, saturated chain species (e.g. 16:0/18:0), whereas 
the methylation pathway results in more diversified long chain and 
polyunsaturated species (e.g. 18:0/20:4) [25]. Disruption of most 
phospholipid biosynthetic pathways leads to embryotic lethality in mice 
(Vance and Vance, 2009). The newly synthesized glycerophospholipids 
are dynamically modified by acyl chain remodeling and translocated 
between membranes of different subcellular organelles [26]. In 
addition, base-exchange represents a minor pathway for synthesis of 
most phospholipids to provide a rapid energy-independent means of 
replenishment (Vance and Vance, 2004). 
The composition of glycerophospholipids differs from one 
organelle to another. Phosphatidylcholine, phosphatidylethanolamine, 
phosphatidylinositol and cardiolipin are the major lipid constituents 
of the mitochondrial membranes, rendering the surface negatively 
charged. Phosphatidylcholine and phosphatidylinositol are bilayer 
lipids with cylindrical molecular shapes, i.e. the cross-sectional 
areas of the lipid head group and the acyl chains are similar. As a 
result these lipids self-assemble into bilayers upon hydration. In 
phosphatidylethanolamine, the cross-sectional area occupied by the 
head group is smaller than that occupied by the acyl chains, resulting 
in a conical molecular shape, and tend to adopt non-bilayer structure 
[27]. 
Sphingolipids
Sphingolipids consist of a sphingoid backbone that is N-acylated 
with various fatty acids to form ceramide species with hundreds of 
distinct head groups. These fatty amino alcohols, including ceramide 
(N-acyl-sphingosine), sphingomyelin and different glycosphingolipids, 
have been implicated in the pathogenesis of metabolic disorders, cancer 
and neurological diseases [28]. The sphingolipids in yeast, mammals 
and insects have very different head group decorations, hydroxylation 
patterns and lengths of fatty acids chains. 
The synthesis of sphingolipids starts in the endoplasmic reticulum 
(ER) from the condensation of serine and palmitoyl coenzyme A 
(CoA) to form 3-ketosphinganine, which is catalyzed by serine 
palmitoyltransferase (Figure 2). The condensation product is reduced 
to dihydrosphingosine (sphinganine), which is then N-acylated by 
one of six ceramide synthases (CerS1-CerS6) with specific acyl chains 
(typically with saturated or mono-unsaturated fatty acids with 14 to 
26 carbons). Dihydroceramides are subsequently dehydrogenated 
to ceramides. Metabolism of ceramide to sphingomyelin and 
glycosphingolipids mainly occurs in the Golgi. Ceramide transfer 
protein is responsible for transportation of ceramides from ER to Golgi 
during sphingomyelin synthesis, whereas vesicular transport is involved 
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Figure1: Synthesis of Glycerophospholipids. Glycerophospholipids are shown in blue; substrates and by-products for glycerophospholipid metabolism are 
shown in black; and all important enzymes are shown in orange. R and R’ in molecule structure represents all possible functional groups derived from fatty 
acid. Abbreviations: CDP, cytidine diphosphate; LPA, lysophosphatidic acid; PA, phosphatidic acid; PgpP, phophatidylglycerolphophate phosphatase; PgpS, 
phophatidylglycerolphophate synthase; PtdsD, phosphatidylserine decarboxylase; PtdsS1, phosphatidylserine synthase-1; PtdsS2, phosphatidylserine 
synthase-2
in glucosylceramide synthesis. Ceramides can also be phosphorylated 
in the Golgi by ceramide kinase to form ceramide-1-phosphate (C1P).
Sphingomyelin is synthesized by the transfer of phosphocholine 
from phosphatidylcholine to ceramide with the generation of 
diacylglycerol, a pathway catalyzed by sphingomyelin synthase and 
representing an interconnection between sphingolipid and glycerolipid 
metabolism. Sphingomyelin is the major component found in the 
membranous myelin sheath that surrounds nerve cell axons [29]. The 
synthesis of glycosphingolipids is initiated by the addition of glucose 
to ceramide by glycosylceramide synthase and requires the transfer 
of glucosylceramide to the trans-Golgi network by four-phosphate 
adaptor protein 2, which also regulates vesicular trafficking from the 
Golgi to the plasma membrane [30].
Sphingolipids are degraded in lysosomes by removing the head 
groups to form ceramides. Sphingomyelinase hydrolyzes sphingomyelin 
and releases ceramide, which may be further degraded by ceramidase 
to sphingosine. Sphingosine can be recycled by reacylation back to 
ceramide, thus fueling the salvage pathway. This reutilization pathway 
plays a significant role in sphingolipid homeostasis. Sphingosine can 
also be phosphorylated by sphingosine kinase to form sphingosine-
1-phosphate (S1P), a bioactive metabolite and a key intermedi ate 
in the sphingolipid-to-glycerolipid metabolic pathway. Irreversible 
degradation of S1P by S1P lyase generates phosphoethanolamine 
and hexadecenal, another key intermediate in the sphingolipid-to-
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HO
Figure 2: Sphingolipid metabolisms. Sphingolipids are shown in blue; substrates and by-products for Sphingolipids metabolism are shown in black; and all important 
enzymes are shown in orange. Biochemical reactions are represented by solid arrows, and inter-organelle transportations are represented with dashed arrows. R 
and R’ in represent possible functional groups derived from fatty acid. Abbreviations: ALDH3A2, fatty aldehyde dehydrogenase; C1P, ceramide-1-phosphate; ER 
endothelium reticulum; Pm-CoA, palmitoyl coenzyme A; S1P, sphingosine-1-phosphate; and TGN, trans-Golgi network.
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glycerolipid metabolic pathway [31]. The fatty alde hyde dehydrogenase 
ALDH3A2 converts hexadecenal to hexadecenoate, which is utilized 
for the formation of palmitoyl-CoA in glycerolipid syn thesis. The 
sphingolipid metabolites, including ceramide, C1P and S1P are 
important signaling molecules that regulate cell growth, survival, 
trafficking and integrity. 
Sterol lipids 
Sterols are constituents of the cellular membranes (myelin in the 
nervous system) and precursors of steroid hormones and bile acids. 
In mammals, cholesterol is the main sterol. Other sterols, including 
ergosterol and 24-methyl sterols, are absent from mammalian cells 
but required for parasitic growth and viability [32]. Cholesterol 
homeostasis is regulated by both endogenous and exogenous pathways 
of cholesterol metabolism. Endogenous cholesterol is synthesized by 
the liver (~10%) and extrahepatic tissues, enters the circulation as a 
component of lipoproteins, and secreted into bile. The brain contains 
more cholesterol than any other organs, and brain cholesterol is almost 
all synthesized locally. Exogenous cholesterol is absorbed in the intestine 
and ultimately enters the circulation as a component of chylomicrons. 
Circulating cholesterol concentrations are maintained by biosynthesis 
as well as absorption. The biochemical pathway of cholesterol synthesis 
is schematically presented in Figure 3. Cholesterol synthesis occurs 
in the cytoplasm and microsomes. It starts from the reduction of 
acetyl-CoA to generate 3-hydroxy-3-methylglutaryl-CoA (HMG-
CoA), which then is converted to mevalonate, a process catalyzed by 
HMG-CoA reductase and using NADPH as a cofactor. Mevalonate 
is then activated by two successive phosphorylations, followed by an 
ATP-dependent decarboxylation to yield an activated isoprenoid 
molecule, isopentenyl pyrophosphate (IPP). The subsequent multiple 
steps of IPP condensation produce squalene. A two-step cyclization of 
squalene produces lanosterol. Through a series of additional reactions 
catalyzed by 7-dehydrocholesterol reductase, lanosterol is converted 
to cholesterol. The post‐lanosterol steps of cholesterol biosynthesis 
are divided into Bloch and Kandutsch–Russell pathways, which share 
enzymatic stages but produce C24 double‐bond reduced cholesterol at 
different steps. HMG-CoA formation is the rate-limiting step in sterol 
synthesis that is controlled by cholesterol levels. If cholesterol uptake 
is low, liver and small intestine will synthesize cholesterol accordingly. 
If HMG-CoA is not needed, such as when intake of dietary cholesterol 
is high, it is degraded quickly to acetoacetate and acetyl-CoA by 
HMG-CoA lyase in the mitochondrial matrix compartment. Steroid 
hormones are generated in specialized organs, such as adrenal glands 
and gonads, each expressing a different set of steroidogenic enzymes. 
All steroid hormones are derived from a single precursor, cholesterol, 
which is transformed to the steroid pregnenolone in the mitochondrial 
matrix by the enzyme CYP11A1. Translocation of cholesterol to 
mitochondria is a key step in steroidogenesis that is accomplished by 
means of transport proteins [33].
In the intestinal lumen, the cholesterol esters are cleaved by 
pancreatic cholesteryl ester hydrolase, which is produced by the 
exocrine pancreas. Free cholesterols, along with other lipids and 
fat-soluble vitamins, are solubilized into micelles and absorbed by 
enterocytes. After absorption, the free cholesterol is re-esterified 
to cholesteryl ester by acyl CoA:cholesterol acyltransferase and 
packaged with other lipids into chylomicrons, which are secreted 
into the mesenteric lymph and ultimately into plasma [34]. Once in 
circulation, chylomicrons are hydrolyzed by lipoprotein lipase at the 
endothelial surface of vessels and reduced to chylomicron remnants, 
which can then be removed from the circulation by the liver or, if they 
are small enough, may be able to penetrate the endothelial surface of 
the arterial wall, where they may contribute to plaque formation [35]. 
Abnormal deposition of cholesterol and cholesterol-rich lipoproteins 
in the arteries is of particular importance clinically, as such deposition 
eventually leading to the development of atherosclerosis. Elevated 
levels of cholesterol in the liver lead to an increased production of very-
low-density lipoprotein (VLDL) and/or low-density lipoprotein (LDL) 
particles, as well as down-regulation of the LDL receptor. Cholesterol is 
acylated before incorporated into VLDL and LDL. VLDLs that contain 
both triglycerides and cholesterol are transported to target organs (e.g. 
adipose tissue and muscle) to unload triglycerides. The remaining 
cholesterol rich LDLs are recognized by other cell types and taken into 
the cells. After endocytosis via LDL receptor, cholesterol is extracted 
within the lysosomal compartment for membrane biosynthesis. The 
LDL receptor recycles to the cell surface. 
Cholesterol overload is prevented by its intracellular esterification 
and subsequent storage in lipid droplets, and by its release. The 
relative contribution of each pathway to cholesterol homeostasis is 
cell type‐specific. Cholesterol is released either as a complex with 
apolipoprotein‐containing lipoproteins via members of the ATP‐
binding cassette transporters or after conversion to oxysterols, a broad 
class of cholesterol derivatives that includes enzymatically derived 
metabolites and compounds generated by non-enzymatic reactions 
[36]. In brain cells, especially neurons, the only route to eliminate 
excess cholesterol is converting it to 24S-hydroxycholesterol by the 
enzyme cholesterol 24-hydroxylase, Cyp46a1. High levels of 24(S),25-
epoxycholesterol, a metabolite generated via blocking the mevalonate 
pathway, have been associated with several neurodegenerative diseases, 
implying that these metabolites play crucial signaling functions [37]. 
The efflux of cholesterol and phospholipid from peripheral cells is 
induced by high-density lipoprotein (HDL) and apolipoprotein A-I 
(apoA-I). Nascent HDL takes up cholesterol from cell membranes 
and other lipoproteins, a process of major biological importance in 
the prevention of cardiovascular disease. Extracellular esterification of 
free cholesterol by lecithin:cholesterol acyltransferase (LCAT) provides 
the driving force for cellular cholesterol removal, which is facilitated 
by ATP binding cassette transporter G1/G4 (ABCG1/ABCG4) and 
ABCA1, and involves the lipidation of lipid-free or lipid-poor apoA-I 
with cellular cholesterol and phospholipids [38]. In situations of 
excess cellular cholesterol, the nuclear liver X receptors induce the 
transcription of ABCA1 and ABCG1 and thus cholesterol efflux. 
Significant proportions of HDL-cholesterol are removed by selective 
uptake through SR-BI into the liver and steroidogenic organs [39]. 
Distribution of lipids 
In circulation, the abnormal distribution of lipoprotein 
particles is closely associated with various disease conditions. 
VLDL, LDL and HDL display characteristic patterns of lipid 
class and species. Phospholipids are unequally distributed across 
lipoproteins. HDL represents a major carrier of phosphatidylcholine, 
lysophosphatidylcholine, phosphatidylethanolamine and its derivative 
plasmalogen, containing over 50% of these lipid classes present in 
human serum [40]. Phosphatidylcholine accounts for 33-45% of 
total lipids in HDL [41]. Comparing to other lipoproteins, HDL is 
enriched in phosphatidylcholine containing polyunsaturated fatty 
acids. Lysophosphatidylcholine, a product of the phosphatidylcholine 
hydrolysis, constitutes up to 15% of HDL but only 2-3% in apoB-
containing lipoproteins. The 16:0 lysophosphatidylcholine is enriched 
in HDL, whereas the 18:0 species is predominantly associated with 
VLDL and LDL. For plasmalogen, a phospholipid with antioxidative 
properties, species containing arachidonic acid residues predominate 
in HDL, whereas species containing 18:1 and 18:2 residues are depleted. 
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Figure 3: Biochemical pathway of cholesterol synthesis. Abbreviations: BP, Bloch pathway; HMG-CoA, 3-hydroxy-3-methylglutaryl-CoA; KRP, Kandutsch–
Russell pathway; and IPP, isopentenyl pyrophosphate.
The plasma phosphatidylethanolamines are mainly the 36:2 and 38:4 
species, which are evenly distributed across VLDL, LDL and HDL. All 
other negatively charged phospholipids, including phosphatidylinositol, 
phosphatidylserine, phosphatidylglycerol and phosphatidic acid are 
present in lipoproteins in low amounts. Compared to LDL, HDL 
is depleted in glycosphingolipids and gangliosides. Sphingomyelin 
accounts for 5-10% of total lipid in HDL, mainly the d18:1/16:0 and 
d18:2/24:0 species. By contrast, LDL contains the largest amount of 
sphingomyelin, accounting for over 50% of plasma sphingomyelin. 
Similarly, ceramides are preferentially carried by LDL (60% of total 
plasma ceramides) compared with HDL (25%) and VLDL (15%) [40]. 
An increased sphingomyelin to phosphatidylcholine ratio enhances 
the susceptibility of LDL to secretory sphingomyelinase, which leads to 
ceramide generation and the formation of aggregated LDL with a high 
atherogenic potential [42]. 
The ratio of shell to core lipids and the composition of the 
amphipathic and neutral lipids are different in the subclasses of 
HDL particles [41]. Steroids in HDL particles are dominated by 
cholesterol (5-10% of lipid) and located in the surface lipid monolayer. 
LCAT catalyzes the trans-esterification between phospholipids and 
cholesterol to produce cholesteryl esters (30-40% of HDL lipids). 
This reaction displaces the cholesterol moiety from the surface lipid 
monolayer into the lipid core of HDL. Cholesteryl esters in HDL are 
present mainly in the form of cholesteryl linoleate [41]. The cholesteryl 
esters can be transferred to apoB-containing lipoproteins in exchange 
for triglycerides, which are located in the HDL lipid core and contain 
mainly species of oleic, palmitic and linoleic acid moieties. The shells of 
large HDL particles are enriched with sphingomyelins and ceramides, 
whereas those of small particles contain more phosphatidylserine, 
phosphatidic acid and phosphatidylcholine. The shells of very small 
particles are enriched in lysophosphatidylcholine and depleted of free 
cholesterol [43]. The side chain distribution is shifted towards more 
unsaturated moieties in smaller particles comparing to larger particles. 
These changes influence the physical properties such as surface charge 
and membrane fluidity of HDL particles. The smaller HDL particles 
have a higher capability to stimulate cholesterol efflux and protect the 
oxidation and pro-thrombotic activity of LDL. 
In mammalian cells, lipids are distributed within membranes 
of multiple compartments that display distinct composition 
of both lipids and their interacting proteins. The membrane 
lipid composition is different between cell types and subcellular 
compartments. Lipid composition of subcellular organelles not only 
influences their membrane structure and function, but also serves 
as a descriptor of an organelle’s identity. For instance, the plasma 
membrane is enriched with phosphatidylinositol 4,5-biphosphate 
(PI(4,5)P2), whereas phosphatidylinositol 4-phosphate (PI(4)P) 
is the predominant phosphoinositide in Golgi. Consequently, the 
protein compositions of these two membrane compartments vary 
significantly, giving rise to distinct morphologies and functional 
properties [44]. Lipids are symmetrically distributed between the 
two leaflets of the membrane bilayer in endoplasmic reticulum. 
On the other hand, the Golgi, endosomal and plasma membrane 
display an asymmetric lipid distribution, with phosphatidylcholine, 
sphingomyelin, and glycosphingolipids enriched at the luminal 
side, and phosphatidylethanolamine, as well as negatively charged 
phospholipids, including phosphatidylinositol and phosphatidylserine, 
enriched at the cytosolic leaflet [45]. Mitochondria contain a complex 
membrane system and the membrane lipid composition depends on 
the interplay with the endoplasmic reticulum, from which some of 
the lipids are imported. The mitochondrial contents of specific lipids, 
such as cardiolipins, can be modulated by dietary intervention, genetic 
manipulation and disease conditions [46]. 
In summary, to understand the dynamic functions of lipids, 
knowledge about the total cellular lipidome alone is not sufficient, as it 
does not provide information about the spatial distribution of the lipids 
within cells. The combined information of the localization and the 
composition of subcellular lipids is a starting point for the molecular 
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elucidation of the lipid networks. Moreover, environmental and 
pathophysiological conditions are to be considered when analyzing the 
dynamic changes of the intracellular and extracellular lipidomes.
Lipid-protein interactions 
Lipids and their metabolites work together with proteins to 
regulate many cellular functions and signal transduction pathways. 
Lipid interactions determine the localization, structure and function 
of proteins [47]. The highly specific interactions between lipids and 
proteins provide a promising area for the discovery and development 
of therapeutic targets [48]. For instance, phosphoinositides 
are an important class of cellular signaling lipids produced by 
phosphatidylinositol phosphate kinases and act on a large number of 
protein effectors [49,50]. Palmitoylation and myristoylation play an 
important role in the trafficking, compartmentalization and membrane 
tethering of proteins [51,52]. The specificity of lipid-enzyme interactions 
determined by the geometry of the catalytic activity is critical for the 
enzyme cyclooxygenase-2 (COX-2) to produce lipid mediators with 
opposing (pro- and anti-inflammatory) functions from chemically 
distinct glycerophospholipids substrates with ω-6 and ω-3 fatty acyl, 
respectively [53]. Thus, understanding lipid–protein interactions has 
important biological or medical implications.
The unique physico-chemical property shared by all lipid species, 
i.e., their hydrophobicity, is accompanied by a poor solubility in an 
aqueous environment. Thus, specific proteins which can reversibly 
and non-covalently associate with lipids, designated as lipid binding 
proteins or lipid chaperones, are needed for the transportation of 
lipids in compartments such as blood plasma and the cellular soluble 
cytoplasm. These lipid binding proteins determine the bio-availability 
of their ligands, and thereby markedly influence the subsequent 
processing, utilization, or signaling effect of lipids [54]. Depending on 
the strength of their interactions with the protein and the consequent 
rate of exchange, lipids have been referred to as different terms. 
The bulk membrane lipids exchange very rapidly, and interact non-
specifically with the protein through the physical properties. The shell 
of lipids at the surface of the protein is usually referred to as annular 
lipids. Other lipids buried within a membrane protein, in deep grooves 
at the protein surface, between transmembrane α-helices, or at the 
protein–protein interface are referred to as non-annular lipids. The 
bindings of non-annular lipids at the interface between transmembrane 
helix bundles can be modulated by hydrophobic inhibitors, such as the 
small molecules that occupy the lipid binding cavities of Ca2 +-ATPase 
[55]. The binding of peripheral membrane proteins to anionic or 
amphipathic lipids constitutes another class of specific lipid-protein 
interactions that are often involving lipid-binding domains, such 
as PH, FYVE, PX, C2 and ENTH, via electrostatic forces [56]. These 
interactions are common in cell signaling and membrane trafficking.
In circulation, lipids are transported by lipoproteins. The various 
lipid species are not only important structural components, but also 
modulate the function of lipoproteins. For example, the antiatherogenic 
potential of HDL can be enhanced by phosphatidylcholine and 
sphingomyelin, whereas adding sphingomyelin in reconstituted HDL 
inhibits LCAT activity [57]. HDL particles are smaller and richer in 
protein contents when compared to other plasma lipoprotein classes. 
Levels of HDL are inversely associated with the risk of coronary artery 
disease and its thrombotic complications [39]. Thus, it has been 
assumed that raising HDL-cholesterol levels reduce cardiovascular 
mortality. Unexpectedly, pharmacologic interventions to increase 
HDL-cholesterol did not translate into the reduction of cardiovascular 
risks [39]. Recent studies reveal that HDL composition, rather than the 
circulating levels, determines its functional properties. Approximately 
half of the total HDL masses are lipids, consisting of phospholipids and 
sphingomyelin (40-60%), cholesteryl esters (30-40%), triglycerides (5-
12%) and free cholesterol (5-10%). More than 200 individual molecular 
lipid species have been identified in HDL particles (Kontush et al., 
2013). In humans, cholesteryl-ester transfer protein (CETP) transfers 
HDL-cholesteryl esters to apolipoprotein B-containing lipoproteins, 
which then are removed by the LDL receptor pathway or the liver-
independent transintestinal excretion of cholesterol [39]. Under 
pathological conditions, such as inflammation, both the proteome and 
lipidome of HDL are significantly altered [58].
Membrane proteins associate with lipids through multiple 
mechanisms, including unspecific hydrophobic association and 
electrostatic interactions, as well as specific covalent bonding [59]. 
The mechanisms by which a protein interacts with lipids determine 
the specificity and affinity of membrane binding, the morphology and 
dynamics of the membrane. The lipid distribution and composition 
in membranes affect protein localization. For example, if the sterol 
concentration were equalized, mitochondrial tail-anchored proteins 
would mistakenly localize to the endoplasmic reticulum of yeast cells 
[60]. Fluxes of cargoes at the Golgi depend on distinct membrane 
structures. There is a gradient of glycerophospholipids across cis-to-trans 
cisternae of the Golgi. Reducing the lipid order of the Golgi membrane 
impairs vesicle fission and cargo export in animal cells [61]. In yeast, 
sphingolipid-enriched and sterol-enriched domains are segregating at 
post-Golgi compartments and involved in protein sorting. The lipids 
and proteins in cell membranes are able to laterally segregate via lipid 
rafts [the nanoscale assemblies containing sphingolipid, cholesterol and 
specific proteins] that play important roles in signal transduction and 
vesicle transportation [62]. The dynamic liquid-liquid immiscibility 
and membrane bioactivity is created by sphingolipid-cholesterol self-
assembly with proteins in lipid rafts [63]. Decoration of proteins with 
glycosylphosphatidylinositols are critical for their trafficking to lipid 
rafts and the outer leaflet of the plasma membrane [64]. Perturbation 
of membrane microstructures by HDL may explain the observed anti-
inflammatory effects in innate immune cells. In macrophages, HDL-
induced cholesterol removal disrupts the formation of cholesterol 
enriched plasma membrane domains (e.g., lipid rafts), leading to the 
inhibition of foam cell formation and inflammation [39]. 
In mitochondria, proteins involved in fusion, division and 
degradation bind to phospholipids and the interactions generate a wide 
array of mitochondrial responses [65]. Cardiolipins are phospholipids 
located at mitochondrial inner membrane and critically involved in 
regulating mitochondrial structure, oxidative phosphorylation and 
biogenesis [66]. Structurally, cardiolipin consists of two phosphatidyl 
residues linked by a glycerol moiety and attached with a total of four 
fatty acyl chains [67]. Cardiolipin binding is essential for the stability 
of respiratory chain supercomplexes and oxidative generation of 
ATP [68]. In mammalian hearts, cardiolipins are enriched with 
symmetric linoleic acid, which is essential for the high affinity binding 
of these lipids to membrane proteins and maintaining mitochondrial 
respiration. Replacement of 18-carbon unsaturated fatty acids with 
those of 22-carbon species is found in myocardial cardiolipins of 
diabetic animals [69]. In fact, the loss of linoleic acid content due to 
cardiolipin remodeling occurs in various cardiac disorders, including 
ischemic/reperfusion injury, heart failure, diabetic cardiomyopathy 
and aging-induced cardiac dysfunction [70-72]. Cardiolipins are bilayer 
preferring lipids that upon charge neutralization, acquire non-bilayer 
propensity that confers negative curvature stress to membranes, which 
is important for processes such as fusion and fission via interacting 
with dynamin-related protein, Mgm1 [65].
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Analytical methods in lipidomics 
The wide range of lipid building blocks produces a large array of 
combinations, especially for sphingolipids and glycerophospholipids. 
Theoretically, rearranging the common eukaryotic lipid motifs (i.e. 
without the consideration of isomeric lipids that differ only in double-
bond position, backbone substitution or stereochemistry) can give 
rise to more than 180,000 phospholipid structures in a given cell. 
The structural diversity of lipids presents considerable challenges to 
comprehensive lipid analysis. For instance, it is almost impossible to 
collect data for all classes of lipids in most biological samples using 
a single method for extraction, chromatography separation and 
analytical detection. 
Lipidomics is to comprehensively elucidate lipid-based 
information, including the identification and quantification of lipids 
and derivatives, and to establish pathways and networks of lipid species 
in biological systems [73]. Increased throughput, higher sensitivity and 
higher chromatographic resolution remain the key goals for lipidomics 
research. The LIPID MAPS Consortium (www.lipidmaps.org) has 
established detailed procedures for sample extraction, separation and 
quantitative analysis for major lipid categories [4]. The structural 
and quantitative analysis of lipids are mainly performed by mass 
spectrometry (MS), with which lipid ions are identified by their mass-
to-charge ratio (m/z). The peak intensity corresponds to the abundance 
of a lipid molecule. Normalization of the intensity to the standards 
enables absolute quantification of the lipid molecules. Fragmentation 
of the lipids specifies their molecular identities for unique lipid species 
and subspecies 
Extraction of Lipids 
Lipids are embedded in complex matrixes. Prior to analysis, 
isolation and/or fractionation are necessary in order to remove any 
non-lipid components, such as proteins, saccharides and other small 
molecules. Generally, two extraction methods are used to separate lipids 
from biological samples. Liquid–liquid extraction allows an instant 
partition of the lipids. The Folch method was originally designed to use 
chloroform/methanol solvent with or without incorporated H2O as the 
extraction matrix [74]. The high efficiency of chloroform/methanol/
H2O extraction method is due to the capability to penetrate through 
cell membrane, higher polarity and stronger interaction with hydrogen 
bond. The proportions of chloroform, methanol and H2O depend on 
the moisture content of the samples. Other liquid-liquid extraction 
methods include the use of hexane/isopropanol solvent [75], the one 
phase butanol/methanol mixture combined with two phases heptane/
ethyl acetate extraction matrix, a methyl tert-butyl ether-based solvent 
[76], a combined extraction with dichloromethane and a methyl tert-
butyl ether/hexafluoroisopropanol mixture [77], and so on.
Solid-phase extraction does not require the partition of lipids in 
solvent/water mixture, but use stationary materials, such as bonded 
silica gel with −CN, −NH2, or diol groups, in combination with different 
elution solvents for lipids separation [78]. For example, aminopropyl 
cartridges are used for sequential extraction of neutral and acidic 
phospholipids. With the application of solvents with increasing 
polarity, efficient isolation of phosphatidylcholine, non-esterified 
fatty acids, cholesterol esters and triacylglycerols can be achieved [79]. 
These cartridges can also be used for fractionation of the subclasses 
lipids, including ceramides, glycosphingolipids, sphingomyelins and 
phosphorylated sphingoid bases [80]. Compared to liquid-liquid 
extraction, solid-phase extraction show an improved selectivity and 
recovery for phospholipids, including phosphosphingolipids and 
glycerophospholipids [81]. Due to its simplicity in operation, reduced 
cost in solvents and easy automation, the popularity of solid-phase 
extraction is growing, especially in targeted lipidomics, whereas liquid-
liquid extraction is more suitable for non-targeted lipid profiling. 
Lipids are widely distributed both inside and outside the cells. 
When whole-cell extracts are used, all information on the spatial 
distribution is lost [27]. Thus, for identification of lipids in organelles 
or membranes, cellular fractionation is critical [82]. In this regard, 
protein markers will allow for the verification of subcellular organelles, 
thus aiding in the preparation of lipid fractions [83]. Furthermore, 
the amount and composition of lipids can be highly variable between 
different types of tissues/cells and at different time during the day 
[84,85]. For example, circulating fatty acids display remarkable 
circadian patterns [86]. Thus, the temporal differences of lipid 
concentrations require time course experiments and the selective 
enrichment of lipid species when they are of low abundance. In this 
regard, metabolic labelling with chemical isotopes of lipid precursors 
followed by extraction and subsequent analysis is a powerful way to 
study kinetics of incorporation and turnover of lipids [87]. For example, 
fatty acid synthesis can be determined by the incorporation of stable 
isotope (D or 13C) -labeled precursors into lipids, such as palmitate, 
phosphatidylcholine and triglycerides, which are then analyzed 
by mass isotopomer distribution analysis [88-92]. During sample 
processing, chemicals can modify lipids. Oxidation of polyunsaturated 
fatty acyls in glycerophospholipids by reactive oxygen species leads to 
the formation of hydroxyls, hemiacetals and furans. Oxidized lipids are 
short-lived, thus complicating analytical capture [93]. In addition, the 
proportion of fatty acyls differs dramatically between organs. The brain 
is very rich in polyunsaturated fatty acyls, such as arachidonic acid 
(C20:4) and docosahexaenoic acid (C22:4), whereas the liver contains 
primarily saturated and monounsaturated fatty acyls. Depending on 
the organ and/or cell types, oxidation produces different lipid reaction 
products, which influence the discovery process of lipid biomarkers 
[94]. A major challenge would be to process the lipid samples without 
changing their structures and local localizations.
Separation and Analysis of Lipids
Fatty acid analysis demands high chromatographic resolution 
to separate those of various chain lengths and to accurately identify 
geometric and positional isomers. The most commonly adopted 
methodology for fatty acid separation is gas chromatography (GC) 
of fatty acid methyl esters (FAME) [95]. GC is a reliable tool for the 
quantitative analysis of complex mixtures of fatty acids. The method 
dates back to the discovery in 1950s that short-chain fatty acids can be 
separated by vapor-phase chromatography [96]. Later on, the protocol 
was improved by converting the long-chain fatty acids to methy esters 
for analysis by GC [97]. GC coupled with mass spectrometry (GC/
MS) has now become a routine procedure with broad application 
to biochemical, biomedical, forensic, agricultural, environmental 
and industrial research. GC with polar columns is suitable for the 
separation of complex fatty acid mixtures. For GC analysis, the polar 
carbonyl groups of fatty acids must first be converted to produce more 
volatile non-polar fatty acid methyl esters (FAMEs) [98]. Analytical 
laboratories frequently apply flame ionization detection (FID) for 
quantification of FAMEs. However, FID does not provide information 
on molecular mass or other structural characteristics for absolute 
discrimination. MS coupled with electron impact ionization (EI) helps 
to solve these problems. Moreover, the sensitivity and selectivity of 
MS methods are particularly advantageous for FAME determination 
in complex biological samples. Thus, the capacity to combine 
spectrometric examination and quantitative determination advances 
of GC-MS is a powerful alternative to GC-FID for FAME analysis [99].
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For GC analysis of lipids, derivatization is usually done to 
substitute the polar groups, such as –COOH, -OH, -NH, and –SH, in 
order to improve their volatility and thermal stability. A wide range of 
derivatization reagents are available for reactions including alkylation, 
acylation and silylation [100-103]. Alkylation reagents modify 
compounds containing acidic hydrogens, such as carboxylic acids 
and phenols, which are converted into either esters or ethers [102]. 
In acylation reactions, compounds containing a labile hydrogen are 
transformed into esters, thioesters and amides. Acylation is commonly 
used to add fluorinated groups to molecules for analysis by electron 
capture detectors (ECD). However, due to the presence of residual 
acids, a purification step is required before injecting the products 
into GC [103]. Silylation produces more volatile and thermally stable 
derivatives that can be injected directly into GC. The reaction replaces 
the labile hydrogen of acids, alcohols, thiols, amines, amides or 
enolizable ketones and aldehydes with a trimethylsilyl group through 
nucleophilic attack (SN2) [100]. When the carboxyl group is derivatized 
with reagents containing a nitrogen atom, the molecule is ionized in 
the mass spectrometer with the nitrogen atom carrying the charge. 
Radical-induced cleavage can occur along the alkyl chain and gives a 
series of relatively abundant ions. Diagnostic ions tend to be generated 
at the sites of double bonds or other functional groups [20,104]. 
For quantification, a mixture of internal standards is added to 
the sample prior to extraction. Each lipid species is quantitated from 
respective standard curves, using the ratio between analyte peak area 
and corresponding internal peak area, which converts the instrumental 
signal into absolute amounts [95]. The absolute quantification 
depends on the signal strength of a single internal standard, usually 
heptadecanoic acid. Mammals cannot make heptadecanoic acid, but 
can take up fatty acids with odd-numbered chains through the diet, 
which interfere with the quantification. In GC/MS, fatty acids are 
reliably quantitated by the stable isotope dilution method, in which 
each analyte is compared to a deuterated analog with similar chemical 
and structural properties [95]. Moreover, by combining with selected 
ion monitoring (SIM), a high sensitivity and specificity can be achieved 
by GC/MS analysis. Intact molecular ions and/or large fragments are 
essential for identification and quantification. EI generates positive 
ions and extensive fragmentation. Thus, a limitation of GC/MS with 
EI is the fragment-rich spectra with low intensities of molecular ions. 
Moreover, the mass spectra rarely contain ions indicative of structural 
features, such as the positions of double bonds [105,106]. As an 
alternative, negative chemical ionization (NCI) of pentafluorobenzyl 
derivatives is applied [95]. However, NCI is a less robust ionization 
method compared with EI and needs to be used in combination with 
certain types of ester derivatives [92]. The NCI GC–MS has been 
demonstrated as a sensitive technique to determine cytochrome P450 
metabolites of arachidonic acid [107]. 
The analysis of geometric isomers is challenging due to their subtle 
differences in chemical and physical characteristics. Separation of 
geometrical isomers in complex samples is most effectively achieved 
by GC using long capillary columns coated with highly polar 
cyanopolysiloxane stationary phases [108]. These columns enable 
the separation of geometric and positional isomers that are not fully 
resolved on columns with less polar stationary phases. However, 
polar columns required for separation of geometric isomers can 
cause co-elution of some saturated and unsaturated fatty acids, thus 
confounding component identification. Some of these concerns can 
be addressed by two-dimensional GC but this requires a complex 
technical arrangement [95]. Alternatively, a pre-purification step using 
silver-ion solid phase extraction with silver-ion impregnated silica can 
be employed to fractionate cis and trans isomers of fatty acids prior 
to capillary GC analysis [109]. Nevertheless, the temperature limit of 
polar columns does not permit the analysis of FAMEs with more than 
30 carbon atoms.
The two soft-ionization techniques including electrospray 
ionization (ESI) and matrix-assisted laser desorption/ionization 
(MALDI) have been introduced in late 1980s and revolutionized 
MS field [110,111]. In contrast to EI and CI, ESI does not require 
the derivatization of fatty acids and generates intact molecular ions. 
It is particularly useful for the analysis of extremely long chain fatty 
acids (VLCFA) that contain up to 36 carbon atoms. The advantages of 
shotgun lipidomics, i.e., direct-infusion using ESI/MS for lipid analysis, 
are high speed and ease of automation. Using ESI, the suppression of 
ionization by matrix components has to be considered, particularly 
for direct MS approaches. Therefore, the application of internal 
standards is mandatory for quantification and relative comparison 
[89]. The addition of two internal standards for each lipid class, e.g., 
a low mass and a high mass species, allows the calculation of the 
ratios against both. By coupling ESI to liquid chromatography (LC), 
the number of lipid classes that can be analyzed has greatly increased. 
LC is applied to separate different molecular species based on the 
polar head groups and the different fatty-acyl chains using normal-, 
polar- or reversed-phase columns, or in combination. Polar stationary 
phases are favorable as they allow the co-elution of the lipid species 
of the same class and internal standards [112]. In contrast, reversed 
phase chromatography usually separates lipid species by chain length, 
thus, can be affected by matrix effects [113]. Both normal phase and 
hydrophilic interaction chromatography are able to differentiate bond 
types (ester/ether), fatty acid combinations and isobaric compounds 
[114]. LC increases the fidelity of lipid identification by the separation 
of isobaric or quasi-isobaric species [115,116]. However, the resolution 
of isometric species is still limited and the problems of ion 7suppression 
by certain lipids are common. MS/MS instruments including two mass 
analyzers separated by a collision cell either in space or in time allow 
the generation of fragment ions of lipids for identification of previously 
uncharacterized lipids and discrimination between lipids with similar 
masses and chemical structures. Fragmentation of an ion of interest 
allows identification of the lipids with high fidelity and a detailed 
understanding of “bonding” between the different building blocks 
(such as fatty acids, sphingoid bases, and head groups). Species with 
low abundance are often analyzed by interfacing MS/MS with liquid 
chromatography (LC–MS/MS). Beam-based MS/MS instruments 
include triple quadrupoles MS, ion trap MS, quadrupole-time-of-
flight MS and time-of-flight MS. These advances in MS form a basis 
for ‘‘shotgun’’ lipidomics in which precursor lipids are determined 
based on characteristic fragment ions [116]. Moreover, MS/MS 
approaches are now available for targeted analysis of different classes 
of lipids in complex mixtures [117,118]. For example, in untargeted 
lipidomics, the crude lipid extracts produce complex mass spectra 
with many different ionized lipids and isobaric species. Head group 
labeling with D9-choline and D4-ethanolamine combined with direct 
infusion ESI-MS/MS allows rapid analysis of phosphatidylcholine and 
phosphatidylethanolamine species in crude lipid extracts from liver 
cells [25]. It should however be noted that the detection of lipid species 
of very low abundance remains a major challenge. More sophisticated 
applications are to be developed for distinguishing isomeric (same 
chemical formula but different structures) and isobaric (ions with 
same mass) species in comprehensive profiling studies of complex 
samples. Ozone-induced or radical-directed dissociation are applied as 
novel approaches to identify the positions of double bonds [119,120]. 
Negative ESI-MS/MS and/or nuclear magnetic resonance are useful for 
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studying complex glycolipids [121].
In summary, due to the highly diversified features of lipids, a 
combination of multiple purification strategies (e.g. total, organellar, 
and subclass lipidomes) and profiling methods (e.g. GC/MS, LC/
MS and others) are required for a comprehensive lipidomic analysis. 
Because of the inclusion of lipid class-specific internal standards, 
lipidomics can provide absolute quantification as well as detailed 
structural information of a large number of different lipid classes 
simultaneously. 
Lipoproteomic studies
Understanding lipidome often requires the investigation of 
molecular interactions between lipids and proteins [122,123]. 
For fully appreciate the biological significance and the potential 
pathophysiological implications of lipids, the type, degree and 
strength of lipid-protein molecular interactions should be carefully 
considered. However, despite lipids being one of the most abundant 
classes of cellular metabolites, our knowledge of lipid-protein 
interactions is rather limited, as it is not a trivial task for searching 
the lipid interactomes. The advancement of mass spectrometry-based 
Lipoproteomic platform has facilitated the development of methods 
for lipid-protein interactions. 
Liposome sedimentation is most frequently used for qualitatively 
measuring interactions between lipids and proteins in the range of 1–20 
μM. Combined with proteomics analysis using Nano-LC-MS/MS, novel 
and unexpected proteins can be identified for those bound to acidic 
phospholipids [124,125], embedded in the lipid nanodiscs [126,127], 
carried along the secretory and the endocytic pathways [128], and 
associated with specific lipid targets [129]. Photoreactive lipids have 
been successfully used in studying lipid-protein interactions. Upon 
UV activation, the photoreactivable groups, such as benzophenones, 
3-trifluorophenyl diazirines, aryl azides, and alkyl diazirines, cross-
link with the nearest protein neighbors to form covalent bonds. 
The labeled proteins are subsequently isolated for identification by 
mass spectrometry. Using this strategy, the dynamic interactions 
between proteins and lipids, including cholesterol, sphingolipids, 
phosphatidylcholine, and phosphatidylinositol have been reported 
[122,130-32]. The combination of clickable, photoreactive lipid 
probes with proteomics approach provides a powerful tool to identify 
unique lipid-protein interactions [133]. For example, S-palmitoylation 
is a post-translational modification required for the trafficking, 
compartmentalization, and membrane-tethering of many proteins. The 
compound 17-octadecynoic acid can serve as a click chemistry probe 
for in situ labeling, identification, and verification of palmitoylated 
proteins [51,134].
In principle, the above mentioned approach using clickable 
photoreactive probes is applicable to lipid-protein interactions in 
membrane. However, an important requirement would be that the 
photoreactivable lipid analogues are efficiently incorporated into the 
membrane. In this case, major challenges include the detection of 
membrane proteins with low expression levels and in live cells [135]. 
When designing an experiment using liposomes to study interactions 
between lipids and membrane proteins, many factors need to be taken 
into account, including lipid composition and molar ratios, membrane 
curvature, pH and salt concentrations of the buffer etc. It is important 
that the lipid composition and other parameters in the assay resemble 
as accurately as possible the relevant membrane organelle [123]. 
For example, if the protein of interest is at the cytoplasmic leaflet of 
the Golgi complex, it is important to include phosphatidylinositol 
4-phosphate in the vesicles, whereas if the protein of interest localizes 
to the inner leaflet of the plasma membrane, phosphatidylinositol 
4,5-biphosphate at the relevant density should be added into the model 
membranes [44]. 
When using sensitive mass spectrometric methods for identification 
and quantification of both proteins and lipids, the extraction methods 
should be modified to minimize the solubilization of lipids surrounding 
the protein [136]. For example, compared to the classical lipoprotein 
isolation techniques by ultracentrifugation, which is too tedious and 
may alter the composition of lipoproteins, fast performance liquid 
chromatography (FPLC) offers rapid and reproducible separation 
of lipoproteins by size [40]. This technique has been proven to be 
sensitive, reproducible and reliable for obtaining detailed cholesterol, 
glycerophospholipid, and sphingolipid composition of the separated 
lipoprotein fractions from a small amount of serum based on ESI-
MS/MS analysis. The method can also be used to identify alterations 
of lipoprotein lipid species in disease conditions. Similarly, a protocol 
has been developed for identification of lipid-protein interactions in in 
vivo assembled complexes. Intact protein-lipid complexes containing a 
protein of interest fused to the tandem-affinity purification (TAP) tag 
are captured from cell lysates in the absence of detergent. After removing 
the contaminated lipids by analytical size-exclusion chromatography, 
lipidomics techniques such as GC- or LC-MS can then be applied to 
measure the co-eluted lipids for identifying the interactions with the 
TAP fusions [137]. 
Data analysis and interpretation 
Data of proteomics is transformed by searching algorithms that 
enable the assignment of protein sequences by comparing experimental 
and theoretical MS fragmentation patterns of proteolytic peptides. In 
the case of lipids, the bioinformatics are different and the needs remain 
largely unmet. The readouts of untargeted lipidomics including the 
retention times during LC or GC separation, the mass-to-charge (m/z) 
ratio, the information on molecular and fragment ions. For targeted 
lipidomics, the data is delivered as a matrix of lipid identities (including 
precursors to fragment ions) and their intensities. Typical procedure of 
analysis includes data processing (peak integration, identification and 
normalization), statistics (univariate or multivariate), and integration 
of functional pathways (e.g., the Kyoto Encyclopedia of Genes and 
Genomes, KEGG). In addition to LIPID MAPS, other lipid databases 
and software packages have been developed, such as LipidView, 
MZmine 2, LipidXplorer, LipID and LipidBank [138-144]. The 
composite spectrum and the molecular formula of lipid entities have 
been launched in the Human Metabolome Database (HMDB). Thus, 
HMDB is used to confirm and extend lipid identifications by matching 
the m/z values to reference masses and taking into account the 
isomeric characteristics. In untargeted lipidomics study, other major 
metabolite databases including Madison Metabolomics Consortium 
Database (MMCD), Metlin and MetaboSearch are also useful [145]. 
Integration of the search results from several databases leads to 
a more comprehensive coverage. In addition, a series of software 
tools and databases (KGML-ED, VANTED, MZmine, and LipidDB) 
can be used for the processing of lipidomics data and biochemical 
pathway reconstruction [146]. However, manual combination of the 
massive search results is generally difficult and there lacks software 
tools that enable simultaneous search against the multiple databases 
and the integration of the results. Although many software packages 
are available for the data analysis of unlabeled lipid species from 
shotgun and LC–MS based approaches, the bioinformatic processing 
of complex data sets that are generated by stable isotope labeling is 
lacking. In addition, computational models to follow the dynamics 
of lipid species metabolism and to integrate data sets from different 
approaches will be very useful for generating a comprehensive picture 
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and revealing the complexity of various lipid species. Considering the 
dynamic distribution of organellar lipidome, whole cell lipidomes 
should be de-convoluted in order to obtain information about the 
subcellular organization. Lipidomic changes at the cellular level can 
indicate changes in subcellular organelles [82].
Large-scale studies for lipid-protein interactions have been 
used for tackling different biological questions, cataloguing or 
identifying potentially novel interactions. To validate the findings, 
statistical analysis based on reference datasets allows the assessment 
of data accuracy, sensitivity, and bias of the methodology [147]. The 
assumption that lipids and proteins interacting with each other are from 
the same pathway, or in different pathways but of similar functions, 
allows one to provide further confirmation based on known proteomic 
or lipidomic networks. Computational analyses of novel interactions 
include sequence comparison, and structural modeling, such as in 
silico prediction of lipid-binding domains [148]. These approaches are 
either used to create training sets for machine learning (classification) 
or abinitio simulations [149]. Based on the structural data (in PDB, 
www.rcsb.org/pdb), the amino acid residue involved in an interaction 
could be determined [150-158]. Generally, all approaches, including 
the statistical analysis of high-throughput experiment and the learning 
and dynamic simulation of molecular interactions, are in their early 
stages and thus limited by the quality and scale of current lipid-protein 
interaction data. With the development of analytical methods and 
accumulation of datasets, more computational approaches could be 
adopted by utilizing network (i.e. pathway analysis and functional 
annotation) and structural (i.e. conservation analysis and building 
domain databases) tools. Finally, integrating the data of lipoproteome 
with other data, i.e. transcriptome and metabolome, would provide a 
more complete depiction of cellular signaling and metabolic processes. 
Concurrently, the resurgence in the computational approaches 
to extract meaningful information from the multidimensional 
“interactomics” data will ultimately provide a better understanding of 
the regulatory systems underlying lipid functions and interactions in 
the context of cellular and organismal physiology.
Concluding remarks 
Abnormal lipid metabolism and function have been closely 
associated with different pathologies such as obesity, cancer, 
atherosclerosis, diabetes, kidney failure, arterial hypertension, 
neurodegenerative and neurological disorders as well as multiple 
sclerosis. There is an expanding number of drugs that target lipid 
metabolic and signaling pathways, including the well-known 
cholesterol-lowering agents (statins) and cyclooxygenase inhibitors. 
Importantly, it is usually not just the change of one particular lipid 
molecule, large parts of the lipidome are remodeled in a coordinated 
manner. Therefore, by combining different approaches for quantitative 
and structural elucidation, lipidomics delivers a multi-parametric 
read-out for disease biomarker discovery, drug development and 
safety assessment, as well as pathophysiological elucidations. 
However, one of the major challenges in lipidomics is to obtain as 
comprehensive information about the lipidome as possible, especially 
on very low abundant lipids. In order to achieve more breakthroughs 
in lipid research, continued developments of new analytical tools are 
necessary to separate isobaric and even isomeric species and improve 
data processing, data mining, identification and interpretation of 
biochemical pathways. 
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